Ygot, Estrella L.
HRN: 24-50-56 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
12/30/2025
01/05/2026
IV
2.5
Q6
Cellulitis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes